China, Nov. 3 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Tenecteplase Bridging Therapy for Late-Window Large Vessel Occlusion Stroke'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600135755
Registration Time: 2026/11/02
Type: Interventional study
Primary Sponsor: Fujian Medical University Union Hospital
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=348220
Published by HT Digital Content Services with permission from Health Daily Digest....